Raj, T. A. Soosay; Smirk, C. L.; Smith, A. L.; Birtles, J.; Morris, S.
June 2008
Archives of Disease in Childhood -- Fetal & Neonatal Edition;Jun2008 Supplement, Vol. 93, pFa19
Academic Journal
No abstract available.


Related Articles

  • Neonatal percutaneous central venous lines: fit to burst. Smirk, C.; Raj, T. Soosay; Smith, A.-L.; Morris, S. // Archives of Disease in Childhood -- Fetal & Neonatal Edition;Apr2009, Vol. 94 Issue 4, pF298 

    Objective: To examine pressure changes in neonatal percutaneous central venous catheters under varying laboratory conditions and to quantify the risks of rupture in clinical practice. Design: We tested 27-gauge polyurethane Premicath and 24-gauge silicone ECC (both Vygon, Norristown, PA)...

  • Ä°ntravasküler Kateter Ä°liÅŸkili Kan Dolaşım Enfeksiyonları: Literatür Özeti. Özsürekçi, Yasemin; Öncel, Eda Karadağ; Ceyhan, Mehmet // Journal of Pediatric Infection / Cocuk Enfeksiyon Dergisi;Mar2013, Vol. 7 Issue 1, p25 

    The use of central venous catheters (CVC) is beneficial for the management of many groups of pediatric patients including low birth weight neonates, children with cancer, and those with chronic diseases that require frequent venous access such as cystic fibrosis and hemophilia. These CVCs are...

  • Cardiopulmonary support during electrophysiological procedures for ventricular tachycardias not haemodynamically tolerated. Zanobini, M; Rossi, Fabiana; Bertera, Antonella; Sandano, Stefania; Costa, Cristina; Fabrizi, Rita; Viola, Simone; Annoni, Andrea; Alamanni, Francesco; Biglioli, Paolo // Perfusion;Mar2003, Vol. 18 Issue 2, p79 

    The objectives of this study were to evaluate the efficacy of percutaneous cardiopulmonary support (CPS) for circulatory assistance during electrophysiological endocavitary procedures for ventricular tachycardia (VT) in high-risk patients. From January to June 1999, eight patients with VT not...

  • Antibiotics in Neonatal Infections: A Review. Fanos, V.; Dall'Agnola, A. // Drugs;Sep1999, Vol. 58 Issue 3, p405 

    The bacteria most commonly responsible for early-onset (materno-fetal) infections in neonates are group B streptococci, enterococci, Enterobacteriaceae and Listeria monocytogenes. Coagulase-negative staphylococci, particularly Staphylococcus epidermidis, are the main pathogens in late-onset...

  • Transcriptome profiling of liver of non-genetic low birth weight and long term health consequences. Miranda, Alberto; López-Cardona, Angela P.; Laguna-Barraza, Ricardo; Calle, Alexandra; López-Vidriero, Irene; Pintado, Belén; Gutiérrez-Adán, Alfonso // BMC Genomics;2014, Vol. 15 Issue 1, preceding p1 

    Background It is believed that the main factors of low prenatal growth in mammals are genetic and environmental. We used isogenic mice maintained in standard conditions to analyze how natural non-genetic microsomia (low birth weight) is produced in inbred mice and its long term effect on health....

  • Assessing risk and preventing pressure ulcers. Monaghan, Jane C. // Patient Care;4/15/1993, Vol. 27 Issue 7, p36 

    Presents a guideline for predicting and preventing pressure ulcers in adults. Incidence and prevalence of pressure ulcers in hospitals and nursing homes in the U.S.; Risk factors; Steps in skin care which improve tissue tolerance to pressure.

  • OWNING YOUR OWN FIRM: Is it for you? Alvarez, Edna R.S.; Dimitriou, Demetrios // ABA Journal;May90, Vol. 76 Issue 5, p64 

    Discusses factors for lawyers to consider when planning to establish their own law firms. Tolerance for risk; Skills to attract clients appropriate to the intended practice; Tolerance for pressure; Having self-reliance and self-sufficiency.

  • Reduced final height and indications for insulin resistance in 20 year olds born small for... Leger, Juliane; Levy-Marchal, Claire // BMJ: British Medical Journal (International Edition);08/09/97, Vol. 315 Issue 7104, p341 

    Investigates the association between low birth weight and increased risk of developing impaired glucose tolerance, insulin resistance and hypertriglyceridaemia in 20 year olds born small for gestational age. Consequences of intrauterine growth retardation such as reduced final height; Risk of...

  • Choosing a first-line drug in the management of elevated blood pressure: What is the evidence? 3: Angiotensin-converting-enzyme inhibitors. Wright, James M. // CMAJ: Canadian Medical Association Journal;8/08/2000, Vol. 163 Issue 3, p293 

    Abstract Elevated blood pressure is associated with an increased risk of cardiovascular illness and death. Efforts to reduce that risk have led to recommendations for a wide array of nondrug and drug therapies. Choosing the optimal first-line drug for hypertensive patients should address a...

  • Urapidil: A Reappraisal of its Use in the Management of Hypertension. Dooley, M.; Goa, K.L. // Drugs;Nov1998, Vol. 56 Issue 5, p929 

    Urapidil is a peripheral postsynaptic α-adrenoceptor antagonist with central agonistic action at serotonin 5-HT receptors. It reduces blood pressure by decreasing peripheral vascular resistance. Oral urapidil decreases blood pressure in patients with mild to moderate essential hypertension...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics